These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 37441162)

  • 1. Hybrid neural network approaches to predict drug-target binding affinity for drug repurposing: screening for potential leads for Alzheimer's disease.
    Wu X; Li Z; Chen G; Yin Y; Chen CY
    Front Mol Biosci; 2023; 10():1227371. PubMed ID: 37441162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integration of Network Pharmacology and Molecular Docking Technology Reveals the Mechanism of the Therapeutic Effect of Xixin Decoction on Alzheimer's Disease.
    Zhang Z; Xu J; Ma S; Lin N; Hou M; Wei M; Li T; Shi J
    Comb Chem High Throughput Screen; 2022; 25(10):1785-1804. PubMed ID: 35616676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Network pharmacology-based strategy to investigate pharmacological mechanisms of Tinospora sinensis for treatment of Alzheimer's disease.
    Zhou F; He K; Guan Y; Yang X; Chen Y; Sun M; Qiu X; Yan F; Huang H; Yao L; Liu B; Huang L
    J Ethnopharmacol; 2020 Sep; 259():112940. PubMed ID: 32389853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Repurposing of phyto-ligand molecules from the honey bee products for Alzheimer's disease as novel inhibitors of BACE-1: small molecule bioinformatics strategies as amyloid-based therapy.
    Nisa N; Rasmita B; Arati C; Uditraj C; Siddhartha R; Dinata R; Bhanushree B; Bidanchi RM; Manikandan B; Laskar SA; Abinash G; Pori B; Roy VK; Gurusubramanian G
    Environ Sci Pollut Res Int; 2023 Apr; 30(17):51143-51169. PubMed ID: 36808033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integration of network pharmacology and molecular docking to explore the molecular mechanism of Cordycepin in the treatment of Alzheimer's disease.
    Ma X; Zhao Y; Yang T; Gong N; Chen X; Liu G; Xiao J
    Front Aging Neurosci; 2022; 14():1058780. PubMed ID: 36620771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Articulating target-mining techniques to disinter Alzheimer's specific targets for drug repurposing.
    G N S HS; Marise VLP; Rajalekshmi SG; Burri RR; Krishna Murthy TP
    Comput Methods Programs Biomed; 2022 Jul; 222():106931. PubMed ID: 35724476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In silico repurposing of antipsychotic drugs for Alzheimer's disease.
    Kumar S; Chowdhury S; Kumar S
    BMC Neurosci; 2017 Oct; 18(1):76. PubMed ID: 29078760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repurposed Drugs as Potential Therapeutic Candidates for the Management of Alzheimer's Disease.
    Shoaib M; Kamal MA; Rizvi SMD
    Curr Drug Metab; 2017; 18(9):842-852. PubMed ID: 28595531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reappraisal of FDA approved drugs against Alzheimer's disease based on differential gene expression and protein interaction network analysis: an in silico approach.
    G N S HS; Ganesan Rajalekshmi S; Murahari M; Burri RR
    J Biomol Struct Dyn; 2020 Aug; 38(13):3972-3989. PubMed ID: 31543038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular docking and molecular dynamics approach to identify potential compounds in
    Tung BT; Hang TTT; Kim NB; Nhung NH; Linh VK; Thu DK
    J Complement Integr Med; 2022 Dec; 19(4):955-965. PubMed ID: 35621378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repositioning of clinically approved drug Bazi Bushen capsule for treatment of Aizheimer's disease using network pharmacology approach and
    Wang T; Chen M; Li H; Ding G; Song Y; Hou B; Yao B; Wang Z; Hou Y; Liang J; Wei C; Jia Z
    Heliyon; 2023 Jul; 9(7):e17603. PubMed ID: 37449101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Network Pharmacology-Based Analysis of Xiao-Xu-Ming Decoction on the Treatment of Alzheimer's Disease.
    Shen Y; Zhang B; Pang X; Yang R; Chen M; Zhao J; Wang J; Wang Z; Yu Z; Wang Y; Li L; Liu A; Du G
    Front Pharmacol; 2020; 11():595254. PubMed ID: 33390981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Repositioning Drugs to the Mitochondrial Fusion Protein 2 by Three-Tunnel Deep Neural Network for Alzheimer's Disease.
    Wang X; Zhong Y; Ding M
    Front Genet; 2021; 12():638330. PubMed ID: 33659028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic Targeting of Repurposed Anticancer Drugs in Alzheimer's Disease: Using the Multiomics Approach.
    Advani D; Kumar P
    ACS Omega; 2021 Jun; 6(21):13870-13887. PubMed ID: 34095679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. De-novo Drug Design, Molecular Docking and In-Silico Molecular Prediction of AChEI Analogues through CADD Approaches as Anti-Alzheimer's Agents.
    Pandey S; Singh BK
    Curr Comput Aided Drug Des; 2020; 16(1):54-72. PubMed ID: 30827255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the Mechanism of Action of Rosemary Volatile Oil in the Treatment of Alzheimer's Disease Using Gas Chromatography -mass Spectrometry Analysis and Network Pharmacology.
    Zhou P; Wang X; Zhao Y; She X; Jia Y; Wang W; Li J; Luo X
    Comb Chem High Throughput Screen; 2023; 26(13):2321-2332. PubMed ID: 36200249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Network Pharmacology-Based Strategy to Investigate the Pharmacologic Mechanisms of Coptidis Rhizoma for the Treatment of Alzheimer's Disease.
    Ye XW; Wang HL; Cheng SQ; Xia LJ; Xu XF; Li XR
    Front Aging Neurosci; 2022; 14():890046. PubMed ID: 35795239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Network Proximity-based computational pipeline identifies drug candidates for different pathological stages of Alzheimer's disease.
    Wu Q; Su S; Cai C; Xu L; Fan X; Ke H; Dai Z; Fang S; Zhuo Y; Wang Q; Pan H; Gu Y; Fang J
    Comput Struct Biotechnol J; 2023; 21():1907-1920. PubMed ID: 36936813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NHGNN-DTA: a node-adaptive hybrid graph neural network for interpretable drug-target binding affinity prediction.
    He H; Chen G; Chen CY
    Bioinformatics; 2023 Jun; 39(6):. PubMed ID: 37252835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repurposing of clinically proven bioactive compounds for targeted treatment of Alzheimer's disease using molecular docking approach.
    Vasanth Kanth TLB; Raha A; Vijay Murali RM; Yuvatha N; Kumaran K; Kirubakaran R; ArulJothi KN
    In Silico Pharmacol; 2023; 11(1):33. PubMed ID: 37920821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.